Riskpilot← Back to searchSign inGet full accessBIGBIO Herlev ApS
APSActiveCVR 35515755Herlev Hovedgade 31Motion picture projection activities · NACE 5914Est. 201345 employees
Revenue 2025
DKK 8,6M
-12% vs 2024
EBITDA margin
27.5%
-16% vs 2024
Equity ratio
48.8%
Financial strength
Net profit 2025
DKK 1,8M
-15% vs 2024
| Revenue | DKK 8,6M | -12% |
| EBITDA | DKK 2,4M | -16% |
| Net profit | DKK 1,8M | -15% |
| Total assets | DKK 17,7M | +11% |
| Equity | DKK 8,6M | +26% |
| Employees | 45 | — |
Legal name
BIGBIO Herlev ApS
CVR number
35515755
Legal form
Anpartsselskab
NACE code
5914 · Motion picture projection activities
Founded
8. oktober 2013
Share capital
DKK 80.000
Employees
45 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er biografdrift.
Address
Herlev Hovedgade 31
Phone
+4529992005
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10.184 | 15.764 | 10.892 | 9.804 | 8.607 |
| Staff expenses | -6.403 | -6.661 | -7.712 | -6.982 | -6.243 |
| EBITDA | 3.781 | 9.103 | 3.180 | 2.821 | 2.364 |
| Depreciation & amort. | -1.035 | -1.357 | -1.231 | -458 | -298 |
| EBIT | 2.745 | 7.746 | 1.949 | 2.364 | 2.065 |
| Net financials | 74 | 140 | 472 | 340 | 239 |
| Profit before tax | 2.819 | 7.887 | 2.421 | 2.703 | 2.304 |
| Tax | 621 | 1.736 | 540 | 597 | 508 |
| Net profit | 2.198 | 6.150 | 1.881 | 2.107 | 1.796 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16.574 | 24.476 | 17.665 | 15.969 | 17.721 |
| Equity | 9.206 | 15.357 | 11.238 | 6.845 | 8.641 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7.368 | 9.119 | 6.426 | 9.124 | 9.079 |
| Total debt | 7.368 | 9.119 | 6.426 | 9.124 | 9.079 |
EBITDA margin
27.5%
This company
15.8%
Market median
+74% vs market
20212025
Equity ratio
48.8%
This company
38.2%
Market median
+28% vs market
20212025
Return on equity
20.8%
This company
18.4%
Market median
+13% vs market
20212025
Net profit margin
20.9%
This company
8.1%
Market median
+158% vs market
20212025
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20212025
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Management | Management | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2013 | |
| Company | 50–66.65% | 50–66.65% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HELO HOLDING ApS
BIGBIO Herlev ApS Board members of BIGBIO Herlev ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Obel Nielsen | Management | 0 companies |
| Anne Louise Obel | Chairman | 0 companies |